Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018

Fig. 2

Retrieved tests for T. cruzi infection per centre in the years 2000-2018 in Germany. Berlin performed in-house ELISA (2000-2018) and in-house IFT (2000-2010). Bonn performed commercial ELISA (2011-2018), in-house IFT (2000-2010), and commercially available RDT (2000-2010); Hamburg performed in-house ELISA, in-house IFT, and PCR (2000-2018); Munich performed in-house ELISA (2000-2018), in-house IFT (2000-2018), and PCR (2013-2018); Tübingen in-house IFT (2009-2018); a*Data could be retrieved for the years 2002-2018; b*Data could be retrieved for the years 2004-2018; c*Only individual positive tests from 2000-2009 could be retrieved

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us